JP Morgan Chase
CBPO

JP Morgan Chase’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

JP Morgan Chase’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,000
Closed -$954K – 6156
2019
Q2 		$954K Hold
10,000
– – ﹤0.01% 3902
2019
Q1 		$913K Buy
+10,000
New +$818K ﹤0.01% 3861
2017
Q3 		– Sell
-400,000
Closed -$45.2M – 5394
2017
Q2 		$45.2M Buy
+400,000
New +$44.7M 0.01% 956

JP Morgan Chase's CBPO Position: Q2 2021 in Review

JP Morgan Chase sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 5,257 shares — an estimated $622K sold.

JP Morgan Chase first reported a position in CBPO in Q3 2014 and held it in 20 quarters. The position peaked at $6.37M in Q2 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • JP Morgan Chase reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • JP Morgan Chase sold 5,257 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $622K.
  • JP Morgan Chase first reported a position in China Biologic Products Holdings, Inc. in Q3 2014 and held it in 20 quarters.
  • JP Morgan Chase's China Biologic Products Holdings, Inc. position peaked at $6.37M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.